InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| pFUSE-hIgG1-Fc | Chimeric single-chain variable fragment-human immunoglobulin G crystallizable... | 2023 | Explor Target Antitumor Ther. | Laopajon W. et al. | DOI: 10.37349/etat.2023.00188 |
| 2'3'-cGAMP | cGAS-STING signalling regulates microglial chemotaxis in genome instability. | 2023 | Nucleic Acids Res. | Talbot E.J. et al. | DOI: 10.1093/nar/gkad1184 |
| Plasmocin® - Mycoplasma Elimination Reagent | 2-Deoxy-glucose ameliorates the peritoneal mesothelial and endothelial barrie... | 2024 | BBRC | Pitaraki E. et al. | DOI: 10.1016/j.bbrc.2023.149376 |
| IAP inhibitor - BV6 | Phosphoproteomics Reveals Novel Insights into the Pathogenesis and Identifies... | 2023 | Inflamm Bowel Dis. | Tao S. et al. | DOI: 10.1093/ibd/izad291 |
| Pan-Caspase inhibitor - Z-VAD-FMK | Phosphoproteomics Reveals Novel Insights into the Pathogenesis and Identifies... | 2023 | Inflamm Bowel Dis. | Tao S. et al. | DOI: 10.1093/ibd/izad291 |
| Zeocin® | Efficient selection of knocked-in pluripotent stem cells using a dual cassett... | 2023 | Cell Rep Methods | Nakade K. et al. | DOI: 10.1016/j.crmeth.2023.100662 |
| LPS-EB (LPS from E. coli O111:B4) | Extracellular vesicles and co-isolated endogenous retroviruses from murine ca... | 2023 | EMBO J. | Cocozza F. et al. | DOI: 10.15252/embj.2023113590 |
| ODN 1585 VacciGrade™ | Tumor nano-lysate activates dendritic cells to evoke a preventative immune re... | 2024 | J Immunol Methods | Dombroski J.A. et al. | DOI: 10.1016/j.jim.2023.113601 |
| ODN 1585 - TLR9 ligand | Tumor nano-lysate activates dendritic cells to evoke a preventative immune re... | 2024 | J Immunol Methods | Dombroski J.A. et al. | DOI: 10.1016/j.jim.2023.113601 |
| G418 (Geneticin) | CD44s and CD44v8-10 isoforms confer acquired resistance to osimertinib by act... | 2024 | Life Sci. | Liu Y.N. et al. | DOI: 10.1016/j.lfs.2023.122345 |
| Puromycin | CD44s and CD44v8-10 isoforms confer acquired resistance to osimertinib by act... | 2024 | Life Sci. | Liu Y.N. et al. | DOI: 10.1016/j.lfs.2023.122345 |
| KO ALPK1 & KO TIFA cells | ALPK1 mutants causing ROSAH syndrome or Spiradenoma are activated by human nu... | 2023 | PNAS | Snelling T. et al. | DOI: 10.1073/pnas.2313148120 |
| HEK-Blue™ Null1-v Cells | ALPK1 mutants causing ROSAH syndrome or Spiradenoma are activated by human nu... | 2023 | PNAS | Snelling T. et al. | DOI: 10.1073/pnas.2313148120 |
| QUANTI-Blue™ | ALPK1 mutants causing ROSAH syndrome or Spiradenoma are activated by human nu... | 2023 | PNAS | Snelling T. et al. | DOI: 10.1073/pnas.2313148120 |
| LumiKine™ Xpress mIFN-β 2.0 | Glabridin improves autoimmune disease in Trex1-deficient mice by reducing typ... | 2023 | Mol Med. | Wen J. et al. | DOI: 10.1186/s10020-023-00754-y |
| Blasticidin | Protocol for producing an adeno-associated virus vector by controlling capsid... | 2023 | STAR Protoc. | Ohba K & Mizukami H. | DOI: 10.1016/j.xpro.2023.102542 |
| Zeocin® | Protocol for producing an adeno-associated virus vector by controlling capsid... | 2023 | STAR Protoc. | Ohba K & Mizukami H. | DOI: 10.1016/j.xpro.2023.102542 |
| R848 (Resiquimod) | Allogeneic NK cells induce monocyte-to-dendritic cell conversion, control tum... | 2023 | J Immunother Cancer | Toffoli E.C. et al. | DOI: 10.1136/jitc-2023-007554 |
| LTA-SA | Mesenchymal stromal cells suppress microglial activation and tumor necrosis f... | 2023 | Cytotherapy | Xu L. et al. | DOI: 10.1016/j.jcyt.2023.11.006 |
| Alhydrogel® adjuvant 2% | Leptospira Lipid A Is a Potent Adjuvant That Induces Sterilizing Immunity aga... | 2023 | Vaccines (Basel) | Varma V.P. et al. | DOI: 10.3390/vaccines11121824 |